List view / Grid view
BioNTech’s commitment aligns with the UK Government’s Plan for Change,…
BioNTech’s commitment aligns with the UK Government’s Plan for Change, which involves accelerating growth of the pharmaceutical industry.
The multi-billion-pound deal provides a boost to the UK’s economy,…
The multi-billion-pound deal provides a boost to the UK’s economy, however it lacks provision to aid the country’s growth ambitions, states the ABPI.
The company now has ABPI membership after a two-year suspension…
The company now has ABPI membership after a two-year suspension involving concerns relating to its compliance with the industry body’s code of conduct.
The Association of the British Pharmaceutical Industry (ABPI) asserts that…
The Association of the British Pharmaceutical Industry (ABPI) asserts that the recommendations will help generate confidence and predictability in medicine regulation in the UK.
Research and innovation is highlighted in the UK’s Autumn Budget…
Research and innovation is highlighted in the UK’s Autumn Budget as a priority ‘crucial national asset’ to aid long-term economic growth.
The UK pharmaceutical industry body has invited proposals on economic…
The UK pharmaceutical industry body has invited proposals on economic investment, support for manufacturing, clinical trials and R&D.
A key goal of the Centre for Process Innovation’s (CPI)…
A key goal of the Centre for Process Innovation’s (CPI) new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland, is to plug the current gap between supply and demand for these innovative medicines.
A new report outlines five critical actions for five of…
A new report outlines five critical actions for five of the UK’s leading manufacturing sectors to ensure sustainable innovation growth is achieved.
If proposed changes to the UK’s Statutory Scheme for branded…
If proposed changes to the UK’s Statutory Scheme for branded medicines is implemented, there will be “a negative impact on new product launches, despite any initial exemption in the first three years,” says Astellas.
Funding to support the UK's life sciences manufacturing, skills and…
Funding to support the UK's life sciences manufacturing, skills and infrastructure has been announced as part of a £650m growth package.
The ABPI and Lilly have responded to the UK government’s…
The ABPI and Lilly have responded to the UK government’s confirmed plans to increase the payment percentage in the Statutory Scheme to control the costs of branded medicines.
The Association of the British Pharmaceutical Industry (ABPI) has urged…
The Association of the British Pharmaceutical Industry (ABPI) has urged immediate government action is needed against the planned UK statutory revenue clawback rate rise for branded medicines.
To support the UK’s investments in manufacturing and R&D, Moderna…
To support the UK’s investments in manufacturing and R&D, Moderna has joined the Association of the British Pharmaceutical Industry (ABPI).
COVID-19 has accelerated the decline in late-stage industry clinical research…
COVID-19 has accelerated the decline in late-stage industry clinical research in the UK, compared to its global peers.
A new framework for how the pharmaceutical industry will use…
A new framework for how the pharmaceutical industry will use health data for research and development of cutting-edge new medicines has opened for consultation.
